Gene Symbol | Gene ID | Gene Info |
---|---|---|
ERG
|
ENSG00000157554.14 | ETS transcription factor ERG |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr21_40033475_40033746 | ERG | 8 | 0.988598 | -0.75 | 2.0e-02 | Click! |
chr21_39867699_39867850 | ERG | 2571 | 0.427330 | 0.71 | 3.1e-02 | Click! |
chr21_39878933_39879084 | ERG | 8601 | 0.315881 | 0.71 | 3.3e-02 | Click! |
chr21_39870358_39870509 | ERG | 26 | 0.988599 | 0.68 | 4.2e-02 | Click! |
chr21_39867883_39868155 | ERG | 2326 | 0.448427 | 0.67 | 4.7e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_197831468_197832400 | 4.70 |
AC073135.3 |
|
5143 |
0.19 |
chr3_141205962_141207110 | 2.95 |
RASA2 |
RAS p21 protein activator 2 |
645 |
0.76 |
chr19_45754620_45755932 | 2.93 |
MARK4 |
MAP/microtubule affinity-regulating kinase 4 |
726 |
0.57 |
chr3_197825673_197826397 | 2.92 |
AC073135.3 |
|
11042 |
0.16 |
chr19_1067222_1068216 | 2.82 |
HMHA1 |
histocompatibility (minor) HA-1 |
222 |
0.85 |
chr17_7239932_7240900 | 2.79 |
ACAP1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
507 |
0.51 |
chr5_1110808_1112337 | 2.78 |
SLC12A7 |
solute carrier family 12 (potassium/chloride transporter), member 7 |
578 |
0.75 |
chr11_63974616_63975431 | 2.77 |
FERMT3 |
fermitin family member 3 |
266 |
0.78 |
chr22_30831807_30831958 | 2.51 |
MTFP1 |
mitochondrial fission process 1 |
10077 |
0.07 |
chr14_101034010_101035263 | 2.45 |
BEGAIN |
brain-enriched guanylate kinase-associated |
192 |
0.93 |
chr8_10663569_10663720 | 2.32 |
ENSG00000252565 |
. |
22079 |
0.14 |
chr11_64512499_64513555 | 2.31 |
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
99 |
0.95 |
chr8_61816196_61816783 | 2.30 |
RP11-33I11.2 |
|
94324 |
0.09 |
chr17_79420863_79421263 | 2.21 |
ENSG00000266189 |
. |
2849 |
0.15 |
chr15_42083533_42083898 | 2.13 |
AC073657.1 |
Uncharacterized protein |
7486 |
0.12 |
chr1_161038546_161039545 | 2.09 |
ARHGAP30 |
Rho GTPase activating protein 30 |
411 |
0.65 |
chr19_3179462_3180177 | 2.07 |
S1PR4 |
sphingosine-1-phosphate receptor 4 |
1083 |
0.38 |
chr16_30195482_30195882 | 2.01 |
RP11-455F5.5 |
|
162 |
0.71 |
chr1_36042987_36043882 | 2.01 |
RP4-728D4.2 |
|
104 |
0.95 |
chr14_24906611_24906867 | 2.00 |
SDR39U1 |
short chain dehydrogenase/reductase family 39U, member 1 |
3518 |
0.13 |
chr21_39748147_39748387 | 1.93 |
KCNJ15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
79419 |
0.11 |
chr4_88480802_88480953 | 1.93 |
SPARCL1 |
SPARC-like 1 (hevin) |
28664 |
0.17 |
chr2_231508439_231508868 | 1.92 |
ENSG00000199791 |
. |
56817 |
0.11 |
chr19_3136242_3137376 | 1.92 |
GNA15 |
guanine nucleotide binding protein (G protein), alpha 15 (Gq class) |
618 |
0.58 |
chr17_56416562_56417088 | 1.91 |
BZRAP1-AS1 |
BZRAP1 antisense RNA 1 |
2106 |
0.19 |
chr8_22462053_22462924 | 1.89 |
CCAR2 |
cell cycle and apoptosis regulator 2 |
63 |
0.94 |
chr1_17508352_17508670 | 1.87 |
PADI1 |
peptidyl arginine deiminase, type I |
23110 |
0.15 |
chr3_160753082_160753543 | 1.87 |
B3GALNT1 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
65643 |
0.12 |
chr6_35279100_35279566 | 1.86 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
1818 |
0.34 |
chr10_6970291_6970646 | 1.84 |
PRKCQ |
protein kinase C, theta |
348205 |
0.01 |
chr18_13464907_13465379 | 1.84 |
LDLRAD4 |
low density lipoprotein receptor class A domain containing 4 |
129 |
0.93 |
chr19_48747671_48748205 | 1.82 |
CARD8 |
caspase recruitment domain family, member 8 |
3618 |
0.15 |
chrX_111125456_111125607 | 1.81 |
TRPC5OS |
TRPC5 opposite strand |
406 |
0.91 |
chr21_45139141_45140358 | 1.80 |
PDXK |
pyridoxal (pyridoxine, vitamin B6) kinase |
756 |
0.66 |
chr6_144471049_144472508 | 1.80 |
STX11 |
syntaxin 11 |
115 |
0.98 |
chrX_3061088_3061239 | 1.76 |
ARSF |
arylsulfatase F |
76289 |
0.09 |
chr17_4336857_4337447 | 1.76 |
SPNS3 |
spinster homolog 3 (Drosophila) |
67 |
0.97 |
chr9_126628860_126629011 | 1.75 |
DENND1A |
DENN/MADD domain containing 1A |
63451 |
0.12 |
chr3_177256670_177257021 | 1.75 |
ENSG00000252028 |
. |
35505 |
0.22 |
chr3_53201143_53201294 | 1.74 |
PRKCD |
protein kinase C, delta |
2073 |
0.29 |
chr12_111843881_111845308 | 1.73 |
SH2B3 |
SH2B adaptor protein 3 |
842 |
0.62 |
chr6_105388737_105389249 | 1.73 |
LIN28B |
lin-28 homolog B (C. elegans) |
15930 |
0.23 |
chr15_64231749_64232239 | 1.71 |
RP11-111E14.1 |
|
11521 |
0.22 |
chr18_77128797_77128948 | 1.70 |
RP11-800A18.4 |
|
24900 |
0.17 |
chr8_61917117_61917333 | 1.70 |
CLVS1 |
clavesin 1 |
52492 |
0.18 |
chr16_85793045_85793254 | 1.69 |
C16orf74 |
chromosome 16 open reading frame 74 |
8414 |
0.11 |
chr1_68026527_68026678 | 1.69 |
ENSG00000207504 |
. |
19792 |
0.23 |
chr11_92499156_92499668 | 1.66 |
RP11-203F8.1 |
|
621 |
0.79 |
chr19_52264413_52264583 | 1.66 |
FPR2 |
formyl peptide receptor 2 |
33 |
0.96 |
chr12_11954842_11955089 | 1.65 |
ETV6 |
ets variant 6 |
49530 |
0.18 |
chr10_27148230_27149879 | 1.65 |
ABI1 |
abl-interactor 1 |
738 |
0.67 |
chr8_8558858_8560022 | 1.63 |
CLDN23 |
claudin 23 |
8 |
0.99 |
chr1_65430726_65432146 | 1.60 |
JAK1 |
Janus kinase 1 |
751 |
0.73 |
chr10_115604050_115604207 | 1.59 |
DCLRE1A |
DNA cross-link repair 1A |
9731 |
0.17 |
chr18_13218069_13218876 | 1.59 |
LDLRAD4 |
low density lipoprotein receptor class A domain containing 4 |
314 |
0.87 |
chr12_70132575_70133879 | 1.58 |
RAB3IP |
RAB3A interacting protein |
47 |
0.95 |
chr1_156124352_156124692 | 1.58 |
SEMA4A |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
360 |
0.78 |
chrX_130964358_130965005 | 1.57 |
ENSG00000200587 |
. |
108303 |
0.07 |
chr10_101088892_101089952 | 1.56 |
CNNM1 |
cyclin M1 |
266 |
0.95 |
chr1_156215307_156216024 | 1.55 |
PAQR6 |
progestin and adipoQ receptor family member VI |
2157 |
0.16 |
chr1_79111525_79111735 | 1.54 |
IFI44 |
interferon-induced protein 44 |
3886 |
0.26 |
chr7_26409747_26409898 | 1.54 |
SNX10 |
sorting nexin 10 |
5877 |
0.23 |
chr7_8300719_8301291 | 1.53 |
ICA1 |
islet cell autoantigen 1, 69kDa |
677 |
0.39 |
chr7_139529212_139529811 | 1.52 |
TBXAS1 |
thromboxane A synthase 1 (platelet) |
401 |
0.9 |
chr8_145689855_145691101 | 1.51 |
CYHR1 |
cysteine/histidine-rich 1 |
60 |
0.88 |
chr7_106505707_106506635 | 1.51 |
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
247 |
0.95 |
chr2_68592484_68592752 | 1.51 |
AC015969.3 |
|
98 |
0.77 |
chr17_33378351_33378574 | 1.50 |
ENSG00000238858 |
. |
3051 |
0.16 |
chr8_10663335_10663486 | 1.50 |
ENSG00000252565 |
. |
21845 |
0.14 |
chr3_197827066_197827292 | 1.50 |
AC073135.3 |
|
9898 |
0.17 |
chr5_176722995_176723146 | 1.50 |
RAB24 |
RAB24, member RAS oncogene family |
7637 |
0.12 |
chr18_74836287_74836734 | 1.49 |
MBP |
myelin basic protein |
3158 |
0.38 |
chr1_31214268_31214551 | 1.49 |
ENSG00000264773 |
. |
2330 |
0.25 |
chr4_121842864_121843514 | 1.48 |
PRDM5 |
PR domain containing 5 |
815 |
0.75 |
chr1_100286219_100286370 | 1.48 |
ENSG00000252226 |
. |
8727 |
0.16 |
chr19_55084758_55085279 | 1.46 |
LILRA2 |
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 |
200 |
0.63 |
chrX_3061320_3061471 | 1.45 |
ARSF |
arylsulfatase F |
76521 |
0.09 |
chr2_58991963_58992114 | 1.45 |
ENSG00000221653 |
. |
476799 |
0.01 |
chr2_61095077_61095367 | 1.44 |
REL |
v-rel avian reticuloendotheliosis viral oncogene homolog |
13434 |
0.18 |
chr1_160676943_160677601 | 1.42 |
CD48 |
CD48 molecule |
4321 |
0.18 |
chr13_91922419_91922570 | 1.42 |
ENSG00000215417 |
. |
80365 |
0.12 |
chr2_16806451_16806602 | 1.41 |
FAM49A |
family with sequence similarity 49, member A |
2182 |
0.46 |
chr17_38500769_38502147 | 1.41 |
RARA |
retinoic acid receptor, alpha |
35 |
0.95 |
chr1_234980313_234980644 | 1.41 |
ENSG00000201638 |
. |
6758 |
0.28 |
chr16_22200871_22201892 | 1.41 |
EEF2K |
eukaryotic elongation factor-2 kinase |
16222 |
0.16 |
chr14_105527834_105528220 | 1.40 |
GPR132 |
G protein-coupled receptor 132 |
3740 |
0.23 |
chr2_103052881_103053032 | 1.39 |
AC007278.3 |
|
2217 |
0.21 |
chr15_38058095_38058397 | 1.39 |
TMCO5A |
transmembrane and coiled-coil domains 5A |
155894 |
0.04 |
chr8_134930430_134930581 | 1.39 |
ENSG00000212273 |
. |
273537 |
0.02 |
chr19_6481304_6482171 | 1.39 |
DENND1C |
DENN/MADD domain containing 1C |
27 |
0.95 |
chr12_11965552_11966421 | 1.39 |
ETV6 |
ets variant 6 |
60551 |
0.15 |
chr2_96809842_96811219 | 1.39 |
DUSP2 |
dual specificity phosphatase 2 |
649 |
0.65 |
chr7_6478083_6478365 | 1.37 |
DAGLB |
diacylglycerol lipase, beta |
9339 |
0.17 |
chr14_78055534_78055772 | 1.37 |
SPTLC2 |
serine palmitoyltransferase, long chain base subunit 2 |
8011 |
0.19 |
chr14_88471433_88472132 | 1.37 |
GPR65 |
G protein-coupled receptor 65 |
314 |
0.88 |
chrX_39964334_39965624 | 1.37 |
BCOR |
BCL6 corepressor |
8323 |
0.32 |
chr15_79862517_79862668 | 1.36 |
KIAA1024 |
KIAA1024 |
137734 |
0.05 |
chr4_2800484_2801318 | 1.36 |
SH3BP2 |
SH3-domain binding protein 2 |
176 |
0.95 |
chr8_29301630_29301781 | 1.36 |
RP4-676L2.1 |
|
91018 |
0.07 |
chr11_1874347_1875032 | 1.36 |
LSP1 |
lymphocyte-specific protein 1 |
489 |
0.65 |
chr16_28506747_28507012 | 1.36 |
CLN3 |
ceroid-lipofuscinosis, neuronal 3 |
24 |
0.94 |
chr2_208095383_208095534 | 1.36 |
AC007879.5 |
|
23518 |
0.19 |
chr6_139947376_139947865 | 1.36 |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
251863 |
0.02 |
chr14_70084691_70084842 | 1.36 |
KIAA0247 |
KIAA0247 |
6453 |
0.25 |
chr13_99195211_99195547 | 1.36 |
STK24 |
serine/threonine kinase 24 |
21127 |
0.2 |
chrX_41565016_41565185 | 1.35 |
GPR34 |
G protein-coupled receptor 34 |
16841 |
0.16 |
chr5_74444070_74444221 | 1.35 |
ANKRD31 |
ankyrin repeat domain 31 |
88558 |
0.09 |
chr1_206729975_206731239 | 1.35 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
114 |
0.96 |
chr2_98334930_98335281 | 1.35 |
ZAP70 |
zeta-chain (TCR) associated protein kinase 70kDa |
5082 |
0.19 |
chr2_127942699_127942861 | 1.35 |
CYP27C1 |
cytochrome P450, family 27, subfamily C, polypeptide 1 |
20563 |
0.22 |
chr4_682374_683342 | 1.34 |
MFSD7 |
major facilitator superfamily domain containing 7 |
74 |
0.94 |
chr2_47406474_47406729 | 1.34 |
CALM2 |
calmodulin 2 (phosphorylase kinase, delta) |
2861 |
0.29 |
chr3_193923608_193923763 | 1.33 |
ENSG00000242201 |
. |
60222 |
0.11 |
chr3_182399899_182401052 | 1.33 |
RP11-225N10.1 |
|
110707 |
0.07 |
chr2_39893102_39893556 | 1.32 |
TMEM178A |
transmembrane protein 178A |
270 |
0.95 |
chr12_4544880_4545031 | 1.32 |
FGF6 |
fibroblast growth factor 6 |
8430 |
0.22 |
chr5_95259980_95260131 | 1.32 |
ELL2 |
elongation factor, RNA polymerase II, 2 |
26034 |
0.15 |
chr7_139311714_139311865 | 1.31 |
CLEC2L |
C-type lectin domain family 2, member L |
102961 |
0.07 |
chr12_123713391_123713550 | 1.31 |
MPHOSPH9 |
M-phase phosphoprotein 9 |
1523 |
0.29 |
chr4_71570546_71572213 | 1.29 |
RUFY3 |
RUN and FYVE domain containing 3 |
861 |
0.36 |
chr2_71701969_71702120 | 1.29 |
DYSF |
dysferlin |
8212 |
0.27 |
chr1_45189026_45189206 | 1.29 |
ENSG00000199377 |
. |
1542 |
0.21 |
chr17_74267700_74268296 | 1.29 |
UBALD2 |
UBA-like domain containing 2 |
6214 |
0.13 |
chr12_52400775_52401965 | 1.28 |
GRASP |
GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein |
646 |
0.62 |
chr19_8566530_8566993 | 1.28 |
PRAM1 |
PML-RARA regulated adaptor molecule 1 |
734 |
0.53 |
chr2_45834098_45834249 | 1.28 |
SRBD1 |
S1 RNA binding domain 1 |
4247 |
0.26 |
chr10_3462183_3462334 | 1.28 |
PITRM1 |
pitrilysin metallopeptidase 1 |
247255 |
0.02 |
chr12_83360051_83360202 | 1.28 |
ENSG00000252220 |
. |
55543 |
0.18 |
chr9_137288293_137289070 | 1.27 |
RXRA |
retinoid X receptor, alpha |
9747 |
0.23 |
chr5_56032034_56032185 | 1.27 |
MAP3K1 |
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
79292 |
0.09 |
chr14_70111746_70111919 | 1.27 |
KIAA0247 |
KIAA0247 |
33519 |
0.18 |
chr9_95787859_95788010 | 1.27 |
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
10592 |
0.19 |
chr7_29377325_29377476 | 1.26 |
CHN2 |
chimerin 2 |
62916 |
0.13 |
chr7_128777310_128777461 | 1.26 |
TSPAN33 |
tetraspanin 33 |
7327 |
0.16 |
chr3_121379230_121379471 | 1.26 |
HCLS1 |
hematopoietic cell-specific Lyn substrate 1 |
395 |
0.81 |
chr1_66838443_66838617 | 1.26 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
18465 |
0.28 |
chr2_182715782_182715933 | 1.26 |
RP11-366L5.1 |
|
40533 |
0.16 |
chr1_156117921_156118144 | 1.26 |
SEMA4A |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
875 |
0.44 |
chr11_65658294_65659563 | 1.26 |
CCDC85B |
coiled-coil domain containing 85B |
1053 |
0.27 |
chr8_1870215_1870366 | 1.25 |
ARHGEF10 |
Rho guanine nucleotide exchange factor (GEF) 10 |
39468 |
0.17 |
chr6_15309152_15309303 | 1.25 |
ENSG00000201367 |
. |
5924 |
0.22 |
chr17_75842607_75842758 | 1.25 |
FLJ45079 |
|
35977 |
0.19 |
chr3_43221570_43221860 | 1.25 |
ENSG00000222331 |
. |
30648 |
0.18 |
chr4_74960008_74960159 | 1.24 |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
4927 |
0.18 |
chr17_35447201_35447427 | 1.24 |
ACACA |
acetyl-CoA carboxylase alpha |
1396 |
0.41 |
chr12_117507997_117508329 | 1.24 |
TESC |
tescalcin |
23527 |
0.23 |
chr1_247570490_247571007 | 1.23 |
NLRP3 |
NLR family, pyrin domain containing 3 |
8710 |
0.18 |
chr7_150148744_150149359 | 1.23 |
GIMAP8 |
GTPase, IMAP family member 8 |
1333 |
0.41 |
chr17_3819186_3819649 | 1.23 |
P2RX1 |
purinergic receptor P2X, ligand-gated ion channel, 1 |
377 |
0.84 |
chr7_5501942_5502166 | 1.23 |
ENSG00000238394 |
. |
22972 |
0.11 |
chr11_122587919_122588091 | 1.23 |
ENSG00000239079 |
. |
9014 |
0.25 |
chr6_109119835_109119986 | 1.23 |
ARMC2 |
armadillo repeat containing 2 |
49709 |
0.16 |
chr8_56985960_56986982 | 1.23 |
ENSG00000238650 |
. |
11 |
0.85 |
chr9_117656065_117656216 | 1.23 |
TNFSF8 |
tumor necrosis factor (ligand) superfamily, member 8 |
36557 |
0.19 |
chr2_8612888_8613039 | 1.23 |
AC011747.7 |
|
202933 |
0.03 |
chr10_111817998_111818272 | 1.23 |
ADD3 |
adducin 3 (gamma) |
50413 |
0.13 |
chr17_79884123_79885283 | 1.23 |
MAFG |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G |
881 |
0.22 |
chr6_41168130_41168571 | 1.22 |
TREML2 |
triggering receptor expressed on myeloid cells-like 2 |
582 |
0.65 |
chr4_141163908_141164258 | 1.22 |
SCOC |
short coiled-coil protein |
14357 |
0.21 |
chr3_101441272_101441423 | 1.22 |
CEP97 |
centrosomal protein 97kDa |
1422 |
0.34 |
chr1_169454193_169456202 | 1.22 |
SLC19A2 |
solute carrier family 19 (thiamine transporter), member 2 |
28 |
0.98 |
chr5_36724203_36724354 | 1.22 |
CTD-2353F22.1 |
|
997 |
0.69 |
chr15_65277663_65278116 | 1.21 |
SPG21 |
spastic paraplegia 21 (autosomal recessive, Mast syndrome) |
1925 |
0.29 |
chr7_115670709_115671033 | 1.21 |
TFEC |
transcription factor EC |
4 |
0.99 |
chr4_84309529_84309680 | 1.21 |
HPSE |
heparanase |
53298 |
0.12 |
chr10_29528746_29529040 | 1.21 |
LYZL1 |
lysozyme-like 1 |
49097 |
0.18 |
chr15_41055526_41056933 | 1.21 |
GCHFR |
GTP cyclohydrolase I feedback regulator |
11 |
0.96 |
chr1_1676260_1677404 | 1.20 |
SLC35E2 |
solute carrier family 35, member E2 |
526 |
0.68 |
chr19_10449910_10450285 | 1.20 |
ICAM3 |
intercellular adhesion molecule 3 |
198 |
0.86 |
chr11_118085317_118085565 | 1.20 |
AMICA1 |
adhesion molecule, interacts with CXADR antigen 1 |
165 |
0.94 |
chr10_106085822_106086336 | 1.20 |
ITPRIP |
inositol 1,4,5-trisphosphate receptor interacting protein |
2603 |
0.2 |
chr3_169755608_169756727 | 1.20 |
GPR160 |
G protein-coupled receptor 160 |
241 |
0.91 |
chr11_65407442_65407916 | 1.20 |
SIPA1 |
signal-induced proliferation-associated 1 |
87 |
0.92 |
chr1_247125385_247125536 | 1.20 |
AHCTF1 |
AT hook containing transcription factor 1 |
30180 |
0.16 |
chr1_28211918_28212086 | 1.19 |
THEMIS2 |
thymocyte selection associated family member 2 |
5760 |
0.12 |
chr7_37960238_37961117 | 1.19 |
EPDR1 |
ependymin related 1 |
245 |
0.94 |
chr15_100049921_100050072 | 1.19 |
AC015660.1 |
HCG1993240; Serologically defined breast cancer antigen NY-BR-40; Uncharacterized protein |
11418 |
0.22 |
chr1_244388042_244388234 | 1.19 |
ENSG00000244066 |
. |
120904 |
0.05 |
chr7_106743915_106744066 | 1.19 |
CTA-360L10.1 |
|
25307 |
0.19 |
chr10_114135452_114136486 | 1.18 |
ACSL5 |
acyl-CoA synthetase long-chain family member 5 |
12 |
0.98 |
chr17_81011742_81011893 | 1.18 |
B3GNTL1 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1 |
2131 |
0.35 |
chr6_51137947_51138146 | 1.18 |
ENSG00000212532 |
. |
191442 |
0.03 |
chr12_123374375_123374668 | 1.18 |
VPS37B |
vacuolar protein sorting 37 homolog B (S. cerevisiae) |
185 |
0.94 |
chr17_29814991_29815971 | 1.17 |
RAB11FIP4 |
RAB11 family interacting protein 4 (class II) |
355 |
0.83 |
chr20_8134073_8134224 | 1.17 |
PLCB1 |
phospholipase C, beta 1 (phosphoinositide-specific) |
20846 |
0.25 |
chr5_76146227_76146557 | 1.17 |
S100Z |
S100 calcium binding protein Z |
468 |
0.79 |
chr14_77422597_77423323 | 1.17 |
ENSG00000266553 |
. |
11148 |
0.21 |
chr22_50319474_50319638 | 1.17 |
CRELD2 |
cysteine-rich with EGF-like domains 2 |
7175 |
0.17 |
chr3_13050979_13051187 | 1.16 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
22547 |
0.24 |
chr11_122545918_122546069 | 1.16 |
UBASH3B |
ubiquitin associated and SH3 domain containing B |
19610 |
0.22 |
chr3_197829934_197830170 | 1.15 |
AC073135.3 |
|
7025 |
0.18 |
chr2_175498105_175498391 | 1.15 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
1059 |
0.58 |
chr11_75272983_75274329 | 1.14 |
SERPINH1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
216 |
0.91 |
chr4_40309799_40310029 | 1.14 |
CHRNA9 |
cholinergic receptor, nicotinic, alpha 9 (neuronal) |
27432 |
0.19 |
chr5_172272383_172272534 | 1.14 |
ERGIC1 |
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
11044 |
0.19 |
chr12_118541450_118542293 | 1.14 |
VSIG10 |
V-set and immunoglobulin domain containing 10 |
118 |
0.96 |
chr10_119795150_119795373 | 1.14 |
RP11-354M20.3 |
|
3987 |
0.24 |
chr3_171779467_171780048 | 1.13 |
FNDC3B |
fibronectin type III domain containing 3B |
15054 |
0.27 |
chr13_50654211_50655703 | 1.13 |
DLEU1 |
deleted in lymphocytic leukemia 1 (non-protein coding) |
1350 |
0.41 |
chr3_151975004_151975217 | 1.13 |
MBNL1 |
muscleblind-like splicing regulator 1 |
10719 |
0.22 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | GO:0033622 | integrin activation(GO:0033622) |
1.1 | 4.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.6 | 1.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 3.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.6 | 2.3 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.6 | 1.2 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.6 | 1.7 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.5 | 1.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.5 | 1.6 | GO:0008615 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.5 | 1.5 | GO:0097576 | vacuole fusion(GO:0097576) |
0.5 | 3.5 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.5 | 1.5 | GO:0010447 | response to acidic pH(GO:0010447) |
0.5 | 1.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.5 | 1.9 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.4 | 1.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.4 | 2.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.4 | 1.3 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.4 | 1.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.4 | 2.1 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.4 | 1.3 | GO:0060242 | contact inhibition(GO:0060242) |
0.4 | 1.2 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.4 | 3.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 1.2 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.4 | 1.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.4 | 1.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 | 1.1 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.4 | 1.9 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.4 | 0.7 | GO:0002883 | hypersensitivity(GO:0002524) regulation of hypersensitivity(GO:0002883) |
0.3 | 1.0 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.3 | 2.1 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
0.3 | 1.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 0.7 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 1.3 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.3 | 2.0 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.3 | 0.3 | GO:0002864 | regulation of acute inflammatory response to antigenic stimulus(GO:0002864) |
0.3 | 1.0 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.3 | 1.0 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.3 | 1.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 0.9 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.3 | 0.9 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.3 | 1.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.3 | 0.6 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.3 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 0.8 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.3 | 0.8 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.3 | 0.8 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.3 | 0.8 | GO:0021508 | floor plate formation(GO:0021508) |
0.3 | 1.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.3 | 1.4 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.3 | 0.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 0.8 | GO:0009405 | pathogenesis(GO:0009405) |
0.3 | 0.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.3 | 0.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.3 | 4.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.3 | 2.5 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.3 | 0.8 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.3 | 0.8 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.2 | 1.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 1.0 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 1.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 1.7 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.2 | 0.5 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 1.2 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 0.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 3.6 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 1.9 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.2 | 0.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.5 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.2 | 0.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 1.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 1.4 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.2 | 0.5 | GO:0046931 | pore complex assembly(GO:0046931) |
0.2 | 0.9 | GO:0002467 | germinal center formation(GO:0002467) |
0.2 | 2.0 | GO:0050718 | positive regulation of interleukin-1 beta production(GO:0032731) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.2 | 1.6 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 0.2 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.2 | 0.7 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 0.7 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.2 | 1.3 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.2 | 1.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.2 | 0.2 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.2 | 0.6 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 1.1 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.2 | 3.8 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.2 | 0.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.2 | 0.6 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 0.6 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.2 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 0.4 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.2 | 1.2 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.8 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 0.2 | GO:0050702 | interleukin-1 beta secretion(GO:0050702) |
0.2 | 0.4 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.2 | 0.8 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 0.8 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.2 | 0.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 0.4 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.2 | 0.2 | GO:0003181 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.2 | 0.4 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.2 | 1.3 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.2 | 0.8 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.4 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.2 | 3.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 5.3 | GO:0046847 | filopodium assembly(GO:0046847) |
0.2 | 0.9 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.2 | 0.2 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.2 | 0.9 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.7 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.5 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 0.7 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.2 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.2 | 0.9 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.2 | 0.9 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.2 | 0.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 0.2 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 0.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.5 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 0.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 0.5 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.2 | 1.0 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.2 | 0.7 | GO:0090398 | cellular senescence(GO:0090398) |
0.2 | 0.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 1.9 | GO:0015695 | organic cation transport(GO:0015695) |
0.2 | 0.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.2 | 0.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 0.7 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 0.8 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.2 | 0.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 3.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.2 | 0.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.5 | GO:0045117 | azole transport(GO:0045117) |
0.2 | 1.4 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 1.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.2 | 2.5 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.2 | 0.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.3 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.2 | 0.6 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 0.2 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.2 | 1.2 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 0.2 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) |
0.2 | 1.8 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 0.8 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.2 | 0.6 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 1.5 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.2 | 0.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 0.2 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.1 | 0.6 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.3 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.1 | 0.6 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.3 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.4 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.1 | 1.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.6 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.1 | 0.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.6 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.1 | 0.7 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.1 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.3 | GO:0001714 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.6 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.6 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.4 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.1 | 0.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.3 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 1.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.3 | GO:0043368 | positive T cell selection(GO:0043368) |
0.1 | 0.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.1 | 0.4 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.1 | 0.4 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 0.3 | GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) |
0.1 | 0.3 | GO:0032616 | interleukin-13 production(GO:0032616) |
0.1 | 0.9 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 2.4 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.1 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.9 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.3 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.9 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.4 | GO:0031060 | regulation of histone methylation(GO:0031060) |
0.1 | 0.1 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.1 | 0.2 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.6 | GO:0015904 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.1 | 0.5 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.7 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.1 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.1 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.1 | 0.9 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 0.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.5 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 0.1 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.1 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.4 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.2 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.1 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.5 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.1 | 0.6 | GO:0046886 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 0.1 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 0.2 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.3 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.8 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.1 | GO:0048284 | organelle fusion(GO:0048284) |
0.1 | 0.2 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.5 | GO:0050663 | cytokine secretion(GO:0050663) positive regulation of cytokine secretion(GO:0050715) |
0.1 | 0.2 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.3 | GO:0021684 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.4 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.1 | 0.4 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.1 | 0.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.6 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.1 | 0.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.3 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.2 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.1 | 0.9 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.2 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.1 | 0.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.2 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.1 | 0.4 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.1 | 0.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.5 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.3 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.7 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 1.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 0.3 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 1.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.3 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.2 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.4 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.1 | 0.2 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.1 | 0.3 | GO:0035307 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
0.1 | 0.3 | GO:0006168 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 1.5 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.4 | GO:0010042 | response to manganese ion(GO:0010042) |
0.1 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.2 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.1 | 0.2 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.2 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) sodium ion export(GO:0071436) |
0.1 | 1.0 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.2 | GO:0060406 | regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) |
0.1 | 0.4 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 1.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 1.6 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.3 | GO:0001840 | neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) |
0.1 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.2 | GO:0001562 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.1 | 0.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.7 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.1 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.1 | 0.1 | GO:0009651 | response to salt stress(GO:0009651) |
0.1 | 0.2 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.3 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.7 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.3 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
0.1 | 0.5 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.1 | 0.6 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.5 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 0.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 1.3 | GO:0030593 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.1 | 0.2 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.1 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.1 | 0.7 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.1 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.3 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.1 | 0.7 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.5 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.1 | 0.2 | GO:0043584 | nose development(GO:0043584) |
0.1 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.1 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.4 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.2 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.2 | GO:0071675 | mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.1 | 0.4 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.1 | 0.2 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.1 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 1.0 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 3.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 1.0 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 0.2 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.6 | GO:1990748 | removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.1 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 1.4 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.1 | 0.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.2 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.2 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.1 | 0.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.1 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.5 | GO:0047496 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 0.2 | GO:0031652 | regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.1 | 0.5 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.1 | 2.8 | GO:0042384 | cilium assembly(GO:0042384) |
0.1 | 0.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.7 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 15.1 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 2.0 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.1 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.1 | 0.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.1 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.1 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.1 | 0.3 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.1 | 0.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.1 | GO:0046958 | nonassociative learning(GO:0046958) |
0.1 | 0.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.2 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.2 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.1 | 0.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.3 | GO:0043324 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.2 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 1.0 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 0.1 | GO:0010954 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.1 | 0.8 | GO:0001504 | neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
0.1 | 0.3 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.1 | 1.5 | GO:0006909 | phagocytosis(GO:0006909) |
0.1 | 0.2 | GO:0031033 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.2 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.1 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) positive regulation of triglyceride lipase activity(GO:0061365) |
0.1 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 0.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.1 | GO:0019049 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.8 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.1 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 1.4 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.4 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.1 | 0.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.3 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.3 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.1 | 0.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.2 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.5 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.1 | GO:1901985 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 2.5 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.1 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 0.1 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 | 0.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.1 | 0.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.1 | 2.4 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.1 | GO:0002704 | negative regulation of leukocyte mediated immunity(GO:0002704) |
0.1 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.1 | 0.2 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.5 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 0.6 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.1 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.1 | 0.9 | GO:0010458 | exit from mitosis(GO:0010458) |
0.1 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.2 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.9 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.3 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.3 | GO:0060323 | head morphogenesis(GO:0060323) |
0.1 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:0019054 | modulation by virus of host process(GO:0019054) modulation by symbiont of host cellular process(GO:0044068) |
0.1 | 0.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.2 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.4 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.5 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.1 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.4 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.1 | GO:0000239 | pachytene(GO:0000239) |
0.1 | 0.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.1 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.4 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.4 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.1 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.2 | GO:1903557 | positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
0.1 | 0.5 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.6 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.2 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.4 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 2.4 | GO:0061025 | membrane fusion(GO:0061025) |
0.1 | 0.1 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.1 | 0.1 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.1 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.1 | GO:0031579 | membrane raft polarization(GO:0001766) membrane raft organization(GO:0031579) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
0.1 | 0.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.1 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.3 | GO:0006027 | aminoglycan catabolic process(GO:0006026) glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.4 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.1 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.1 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.1 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.4 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.1 | 0.4 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.0 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.0 | 0.1 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.4 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.0 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.6 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.0 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.4 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
0.0 | 1.1 | GO:0006885 | regulation of pH(GO:0006885) |
0.0 | 0.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.0 | 0.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.7 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.1 | GO:0010800 | regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.5 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.2 | GO:1903426 | regulation of nitric oxide biosynthetic process(GO:0045428) regulation of reactive oxygen species biosynthetic process(GO:1903426) |
0.0 | 0.0 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.2 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.0 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) |
0.0 | 0.4 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.3 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 0.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.1 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.2 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.0 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.0 | 0.7 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.1 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.3 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.0 | 1.2 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.0 | 0.3 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.5 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.4 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.2 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.6 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.0 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.2 | GO:0030277 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.6 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.4 | GO:0002285 | lymphocyte activation involved in immune response(GO:0002285) |
0.0 | 0.1 | GO:0044254 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.2 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.1 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 0.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.5 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.1 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.0 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 1.2 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.0 | 0.1 | GO:0071732 | cellular response to nitric oxide(GO:0071732) cellular response to reactive nitrogen species(GO:1902170) |
0.0 | 0.1 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.0 | 0.2 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.2 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.0 | 0.1 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.0 | 0.1 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.2 | GO:0090329 | regulation of DNA-dependent DNA replication(GO:0090329) |
0.0 | 0.1 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.4 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.3 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) negative regulation of cAMP biosynthetic process(GO:0030818) |
0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) transcription factor import into nucleus(GO:0042991) |
0.0 | 0.0 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.0 | 0.4 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.4 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.4 | GO:0007033 | vacuole organization(GO:0007033) |
0.0 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.9 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.0 | 0.1 | GO:0031427 | response to methotrexate(GO:0031427) |
0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.0 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 2.6 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.1 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 1.8 | GO:0051346 | negative regulation of hydrolase activity(GO:0051346) |
0.0 | 0.1 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.5 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.3 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 4.5 | GO:0006954 | inflammatory response(GO:0006954) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.0 | 0.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.2 | GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching(GO:0060678) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.4 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.2 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.0 | GO:0043297 | apical junction assembly(GO:0043297) |
0.0 | 0.0 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.1 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.0 | 0.1 | GO:0070918 | dsRNA fragmentation(GO:0031050) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.0 | 0.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.0 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
0.0 | 0.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 3.3 | GO:0050776 | regulation of immune response(GO:0050776) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.0 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.0 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.0 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.0 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 0.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.0 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.1 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.0 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.2 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.0 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.0 | 0.3 | GO:0051899 | membrane depolarization(GO:0051899) |
0.0 | 0.0 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.3 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.0 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.0 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.2 | GO:0035601 | protein deacetylation(GO:0006476) protein deacylation(GO:0035601) macromolecule deacylation(GO:0098732) |
0.0 | 0.1 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.0 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.0 | 0.5 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.3 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.0 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.0 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 2.2 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.0 | GO:0003159 | endocardium development(GO:0003157) morphogenesis of an endothelium(GO:0003159) endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.0 | 0.0 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.4 | GO:0042552 | myelination(GO:0042552) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.2 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.0 | 0.0 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.4 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
0.0 | 0.0 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.0 | 0.1 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.0 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.6 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.0 | 0.0 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.0 | 0.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.0 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0006595 | polyamine metabolic process(GO:0006595) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.0 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.0 | 0.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.0 | 0.0 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.0 | GO:0050795 | regulation of behavior(GO:0050795) |
0.0 | 0.0 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.0 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.0 | 0.1 | GO:0051238 | sequestering of metal ion(GO:0051238) |
0.0 | 0.0 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.0 | 0.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.4 | 1.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.4 | 2.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 1.1 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.3 | 2.7 | GO:0002102 | podosome(GO:0002102) |
0.3 | 4.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 0.3 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 1.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 1.0 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 0.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 1.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 0.2 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 1.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.2 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 0.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 0.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 0.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 0.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 1.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.7 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 1.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 1.0 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.9 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.1 | 0.8 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 2.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 1.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 1.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.4 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 1.3 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.2 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.1 | 0.3 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.1 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 3.2 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.6 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 5.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 2.1 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 2.8 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 0.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.7 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.6 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.3 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 1.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.2 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.1 | 1.4 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.6 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 2.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 1.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 4.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.2 | GO:0060198 | clathrin-sculpted vesicle(GO:0060198) |
0.1 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 1.0 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 4.9 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 0.7 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) |
0.1 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.1 | GO:0038201 | TORC1 complex(GO:0031931) TOR complex(GO:0038201) |
0.1 | 0.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.2 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 1.1 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 1.3 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.5 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 2.0 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.6 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.4 | GO:0030313 | cell envelope(GO:0030313) |
0.0 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 4.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.5 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.2 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.3 | GO:0099738 | apical cortex(GO:0045179) cell cortex region(GO:0099738) |
0.0 | 0.4 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.2 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.2 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.7 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 1.8 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.5 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 1.7 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 0.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.3 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.3 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.5 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 1.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.1 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.0 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.2 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.5 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 1.0 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.5 | GO:0009295 | nucleoid(GO:0009295) |
0.0 | 0.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 76.9 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.3 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.0 | 0.1 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.2 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.2 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.0 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.3 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 14.9 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.0 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 3.6 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.6 | 0.6 | GO:0019863 | IgE binding(GO:0019863) |
0.6 | 1.8 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.6 | 1.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.5 | 2.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.5 | 1.5 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.5 | 1.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.5 | 1.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.5 | 1.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 2.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.4 | 4.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 1.3 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.4 | 1.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 1.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.4 | 2.0 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.4 | 1.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.4 | 1.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.4 | 1.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 1.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 1.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 0.3 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.3 | 1.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 2.7 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 2.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 1.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 1.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 0.3 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.3 | 2.4 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.3 | 1.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 1.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 1.4 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 1.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.3 | 4.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 0.5 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.3 | 1.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 0.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.3 | 2.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.3 | 0.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 1.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 0.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 1.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 4.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 2.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 0.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 3.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.2 | 2.0 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 0.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.7 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 0.8 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 1.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 1.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 1.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 1.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 1.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.8 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 2.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 1.7 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 1.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 2.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.2 | 1.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 0.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 4.0 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.2 | 0.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.5 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.2 | 1.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.8 | GO:0004396 | hexokinase activity(GO:0004396) |
0.2 | 0.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 0.8 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.2 | 0.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 0.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.6 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.2 | 1.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.9 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.2 | 2.5 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.2 | 0.5 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.5 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 2.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 0.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 0.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 1.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.4 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 1.0 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 2.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.8 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 1.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.6 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.4 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.4 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 0.4 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 1.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 2.1 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 1.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.8 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 1.5 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.1 | 4.0 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.9 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.5 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.9 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.6 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 4.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.4 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 0.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.6 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.1 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.1 | 0.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.7 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 1.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.3 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.9 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.4 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 1.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.6 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 4.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.6 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 1.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.3 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 1.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.3 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 1.0 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.9 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 1.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.3 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.9 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.1 | 1.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 1.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.3 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.7 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 1.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 1.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 2.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.3 | GO:0001159 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.1 | 1.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.1 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.5 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 1.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 1.7 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 1.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 1.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.3 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.4 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.2 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.6 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.2 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 1.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.2 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.1 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.7 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.1 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 1.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 1.9 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 1.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 16.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 1.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.1 | 0.9 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.9 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.2 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.2 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 5.8 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.2 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.1 | 0.4 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.1 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.3 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 0.3 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.2 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.1 | GO:0004529 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 1.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.1 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.1 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.0 | 0.2 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 1.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.2 | GO:0080032 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.6 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.4 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.7 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 1.5 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.4 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.2 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 1.8 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.0 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.1 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.0 | 0.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.6 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.5 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.2 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.1 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.0 | 1.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.1 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 1.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.1 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 1.6 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 1.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.3 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.0 | 0.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.2 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.2 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.0 | GO:0015440 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.0 | 3.5 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.0 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.0 | 0.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.0 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.1 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.0 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.0 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) |
0.0 | 0.2 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 0.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.3 | 11.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 17.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 7.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 2.6 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 2.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.3 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.3 | 3.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 2.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 0.7 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 7.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 5.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 5.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 1.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 2.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 1.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 5.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 2.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 2.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 3.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 1.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 2.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.8 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 6.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 2.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 1.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 1.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 1.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 2.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 1.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.7 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 6.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 2.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 9.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 3.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 5.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 1.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 3.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 2.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 4.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 3.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 2.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 1.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 0.8 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 1.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 3.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.2 | 2.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 2.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 0.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 8.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 0.2 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.2 | 1.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 1.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 1.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 2.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.1 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.1 | 2.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 4.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 2.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.5 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 0.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 1.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 0.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 1.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 7.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 3.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 3.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 0.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 0.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.3 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.1 | 2.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 1.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.9 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 1.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.5 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 1.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.2 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.1 | 0.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 1.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 1.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 2.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.6 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.3 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.0 | 1.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.5 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 1.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.9 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 2.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 2.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 1.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.3 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.0 | 0.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.0 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 1.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 2.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 1.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.5 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.6 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.3 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |